Omicron: Everything We Know About New Covid 19 Variant Causing Fresh Panic

• The first case of Omicron was reported in South Africa on November 24, and since then, the strain has become a matter of global concern
• According to preliminary information from experts, Omicron has a large number of mutations compared to other variants
• Available data suggests people who had previously contracted COVID-19 could become reinfected more easily with Omicron than other Variants of Concern

Omicron, also identified as B.1.1.529, is a new variant of COVID-19 that has been declared a Variant of Concern (VOC) by the World Health Organisation (WHO).

A VOC is a strain with new characteristics that can pose a danger to the community and present new challenges to scientists and medical experts.

The first case of Omicron was reported in South Africa on November 24, and since then, the strain has become a matter of global concern.

Read also

Covid 19: Lindiwe Zulu tests positive, Omicron cases rise

On November 26, two days after the first case was reported to WHO, the Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) met and assessed mutations and behaviour of the Omicron variant.

Mutations

According to preliminary information from experts, the variant has a large number of mutations, some of which are said to be “worrying”.

Maria Van Kerkhove, WHO’s COVID-19 Technical Lead, said the Omicron strain was designated as a VOC because it has some “worrying” characteristics.

“It has a large number of mutations and some of these mutations have some worrying characteristics,” Van Kerkhove said.

Transmissibility

Although preliminary information suggests Omicron’s transmissibility rate has been fast ever since the strain was discovered, it has not been established whether or not it is faster than all the other variants, including Delta.

Read also

Travel ban: WHO says keep borders open, tourism industry takes a knock

“The number of people testing positive (for Omicron) has risen in areas of South Africa affected by affected by this variant, but epidemiologic studies are underway to if it is because of Omicron or other factors,” said WHO in a statement.

However, available data suggests people who had previously contracted COVID-19 could become reinfected more easily with Omicron than other Variants of Concern.

Scientists have further established that the B.1.1.5.529 variant has a “growth advantage” over other strains.

“Several labs have indicated that for one widely used PCR test, one of the three target genes is not detected (called S gene dropout or S gene target failure), and this test can therefore be used as a marker for this variant, pending sequencing confirmation.

Using this approach, this variant has been detected at faster rates than previous surges in infection, suggesting that this variant may have a growth advantage,” said WHO in a statement.

Read also

Covid19: Vaccines are likely to protect against the new variant, NICD says as more cases are reported

Severity of Omicron

It is not yet clear whether infection with Omicron causes more severe disease compared to infections with other variants.

“Preliminary data suggests that there are increasing rates of hospitalisation in South Africa, but this may be due to increasing overall numbers of people becoming infected, rather than a result of specific infection with Omicron,” WHO said in its latest update on Omicron.

Further, there is currently no information to suggest that symptoms associated with Omicron are different from those from other variants.

Effectiveness of vaccines against Omicron

With a large number of mutations and growth advantages, some experts say it might be a bit challenging to contain Omicron using existing protocols, including vaccination.

However, WHO has allayed the fears and noted studies are underway in South Africa and other countries to better understand the severity, transmissibility, and characteristics of Omicron before making conclusions.

“Vaccines remain critical to reducing severe disease and death, including against the dominant circulating variant, Delta. Current vaccines remain effective against severe disease and death,” a statement from WHO suggested.

Read also

New Covid19 variant with 32 mutations detected in 3 countries, South Africans are against lockdown

White House Chief Medical Advisor Dr Anthony Fauci said it might take at least two weeks to understand the behaviour of the new variant and determine whether or not existing vaccines can minimise the risk.

Fauci, however, exuded confidence existing vaccines can still offer protection against the new variant.

Tests and treatment

The widely used PCR tests are still effective in detecting the Omicron variant. However, WHO noted studies are ongoing to determine whether there is any impact on other types of tests, including rapid antigen detection tests.

On treatment, WHO still recommends the use of Corticosteroids and IL6 Receptor Blockers for patients with Omicron and other severe COVID-19 strains.

Lindiwe Zulu tests positive for Covid-19

In other news, Briefly News reported that Lindiwe Zulu, the Minister of Social Development, has announced that she has tested positive for Covid-19. She went for a viral swab test on Sunday (28 Nov) after she started experiencing a sore throat.

Read also

Covid 19: Experts say lockdown not necessary as 4th wave approaches, Gauteng figures rising

Zulu says she does not feel that her health is badly affected by the virus, which she attributes to being fully vaccinated. She is self-isolating and will work from home.

The minister used the opportunity to encourage her fellow South Africans to get vaccinated so that the fourth wave is not as severe as the previous three, TimesLIVE reports.

Source: Briefly News